microRNA-155 regulates angiotensin II type 1 receptor expression in umbilical vein endothelial cells from severely pre-eclamptic pregnant women

International Journal of Molecular Medicine

Volumn 27, Issue 3, 2011, Pages 393-399

  Cheng, Weiwei ^a   Liu, Te ^a,b   Jiang, Feizhou ^a   Liu, Chunmin ^a   Zhao, Xinrong ^a   Gao, Yongtao ^a   Wang, Hui ^a   Liu, Zhixue ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b DONGHUA UNIVERSITY   (China)

^c TONGJI UNIVERSITY   (China)

Author keywords

Angiotensin II; Angiotensin II type 1 receptor; Extracellular signal related kinase 1 2; miR 155; Pre eclampsia

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; NORTHERN BLOTTING; PLASMID; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; UMBILICAL VEIN; WESTERN BLOTTING;

ADULT; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PRE-ECLAMPSIA; PREGNANCY; RECEPTOR, ANGIOTENSIN, TYPE 1; UMBILICAL VEINS;

EID: 79551596997     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.598     Document Type: Article

References (36)

1. Steinberg G, Khankin EV and Karumanchi SA: Angiogenic factors and preeclampsia. Thromb Res 123 (Suppl. 2): S93-S99, 2009.
2. Mounier-Vehier C and Delsart P: Pregnancy-related hypertension: a cardiovascular risk situation. Presse Med 38: 600-608, 2009 (In French).
3. Thangaratinam S, Coomarasamy A, O'Mahony F, et al: Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review. BMC Med 7: 10, 2009.
4. Hofmeyr GJ and Belfort M: Proteinuria as a predictor of complications of pre-eclampsia. BMC Med 7: 11, 2009.
5. Scalera F, Fischer T, Schlembach D and Beinder E Serum from healthy pregnant women reduces oxidative stress in human umbilical vein endothelial cells. Clin Sci (Lond) 103: 53-57, 2002.
6. Myatt L and Webster RP: Vascular biology of preeclampsia. J Thromb Haemost 7: 375-384, 2009.
7. Stepan H: Angiogenic factors and pre-eclampsia: an early marker is needed. Clin Sci (Lond) 116: 231-232, 2009.
8. Cudihy D and Lee RV: The pathophysiology of pre-eclampsia: current clinical concepts. J Obstet Gynaecol 29: 576-582, 2009.
9. Tone A, Shikata K, Ogawa D, et al: Changes of gene expression profiles in macrophages stimulated by angiotensin II - angiotensin II induces MCP-2 through AT1-receptor. J Renin Angiotensin Aldosterone Syst 8: 45-50, 2007
10. Dzau VJ: Vascular renin-angiotensin system and vascular protection. J Cardiovasc Pharmacol 22 (Suppl. 5): S1-S9, 1993.
11. Diet F, Pratt RE, Berry GJ, Momose N, Gibbons GH and Dzau VJ: Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 94: 2756-2767, 1996.
12. Chen XL, Tummala PE, Olbrych MT, Alexander RW and Medford RM: Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 83: 952-959, 1998.
13. Luzi E, Marini F, Sala SC, Tognarini I, Galli G and Brandi ML: Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res 23: 287-295, 2008.
14. Zhang J, Du YY, Lin YF, et al: The cell growth suppressor, mir-126, targets IRS-1. Biochem Biophys Res Commun 377: 136-140, 2008.
15. Yu B, Chapman EJ, Yang Z, Carrington JC and Chen X: Transgenically expressed viral RNA silencing suppressors interfere with microRNA methylation in Arabidopsis. FEBS Lett 580: 3117-3120, 2006.
16. Bartel DP: microRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
17. Lee RC, Feinbaum RL and Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854, 1993.
18. Carrington JC and Ambros V: Role of microRNAs in plant and animal development. Science 301: 336-338, 2003.
19. Wang Y, Keys DN, Au-Young JK and Chen C: MicroRNAs in embryonic stem cells. J Cell Physiol 218: 251-255, 2009.
20. Chen X, Ba Y, Ma L, et al: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006, 2008.
21. Mitchell PS, Parkin RK, Kroh EM, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
22. Gilad S, Meiri E, Yogev Y, et al: Serum microRNAs are promising novel biomarkers. PLoS One 3: e3148, 2008.
23. Jiang S, Zhang HW, Lu MH, et al: MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 70: 3119-3127, 2010.
24. Eis PS, Tam W, Sun L, et al: Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 102: 3627-3632, 2005.
25. Wu S, Huang S, Ding J, et al: Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region. Oncogene 29: 2302-2308, 2010.
26. Landgraf P, Rusu M, Sheridan R, et al: A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414, 2007
27. Teng G and Papavasiliou FN: Shhh! Silencing by microRNA-155. Philos Trans R Soc Lond B Biol Sci 364: 631-637, 2009.
28. Martin MM, Lee EJ, Buckenberger JA, Schmittgen TD and Elton TS: MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J Biol Chem 281: 18277-18284, 2006.
29. Sethupathy P, Borel C, Gagnebin M, et al: Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 81: 405-413, 2007
30. Martin MM, Buckenberger JA, Jiang J, et al: The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microrna-155 binding. J Biol Chem 282: 24262-24269, 2007
31. Ko Y, Totzke G, Seewald S, et al: Native low-density lipoprotein (LDL) induces the expression of the early growth response gene-1 in human umbilical arterial endothelial cells. Eur J Cell Biol 68: 306-312, 1995.
32. Uemura H, Hasumi H, Ishiguro H, Teranishi J, Miyoshi Y and Kubota Y: Renin-angiotensin system is an important factor in hormone refractory prostate cancer. Prostate 66: 822-830, 2006.
33. Kluiver J, Haralambieva E, de Jong D, et al: Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer 45: 147-153, 2006.
34. van den Berg A, Kroesen BJ, Kooistra K, et ah High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer 37: 20-28, 2003.
35. He M, Xu Z, Ding T, Kuang DM and Zheng L: MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta. Cell Mol Immunol 6: 343-352, 2009.
36. Huang S, He X, Ding J, et al: Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-β-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int J Cancer 123: 972-978, 2008.